ArticleTargeted oncology2020

Efficacy, Prognostic Factors, and Safety Profile of Enzalutamide for Non-metastatic and Metastatic Castration-Resistant Prostate Cancer: A Retrospective Single-Center Analysis in Japan.

Motohiro Fujiwara et al.PubMed ↗Publisher ↗

No numbers read from the abstract.